PharmiWeb.com - Global Pharma News & Resources

Company Directory

PharmiWeb's Pharma Company Directory is a comprehensive and searchable listing of organisations within the Pharma, Biotech & Life Sciences sector. Use it to find partner organisations, suppliers, or even a company to work for!

As an organisation, a basic listing is FREE, and can raise your profile in the industry, making you visible to thousands of monthly site visitors.

To add your organisation to the directory, simply register as a contributor and add your organisation's details. You can also upgrade to a premium listing for only £500/year, this offers even greater scope for added content (more photos, more links, more copy), and even more exposure.

Note that we only accept contributions relating to the Pharma industry and that it will typically take 2 working days to approve (or otherwise) your details. Once approved, you will also be able to contribute press releases and event details to our site.

Create a free account to list your company for free!

At BioTalent we believe that you deserve to be working in partnership with passionate industry experts who combine exceptional market knowledge with integrity and energy to save you time and effort recruiting in a competitive market. Our core values set a precedent for all that we do and make sure we live up to our aim.
3B Pharmaceuticals GmbH (3BP) is a German biotechnology company developing targeted radiopharmaceutical drugs and diagnostics for oncology indications with a high unmet medical need. As a leader in peptide discovery and optimization, 3BP has built a technology platform extending from hit identification to early clinical development.
Founded in February 2014, 4D pharma is a world leader in the development of Live Biotherapeutics, a novel and emerging class of drugs, defined by the FDA as biological products that contain a live organism, such as a bacterium, that is applicable to the prevention, treatment or cure of a disease.
ABHI supports the HealthTech community to provide products and services that help people live healthier lives. As the voice of the industry, we show the value of health technology and overcome barriers to people benefitting from it now and in the future. Members include leading multinationals through to small and medium sized enterprises.
ADC Bio is an innovative biotechnology company. Specialising in antibody drug conjugates since 2010. We are 100% focused on ADCs and developing new process technology. To speed, simplify and significantly lower the production costs of the latest generation of anticancer blockbuster ADC drugs.
Our teams are highly successful at consistently advocating for our customers, engaging with applicants about your roles, using tried and tested methods.
Synexus, Acurian, and Optimal are now AES. AES owns the most fully identified patient data. And we own the world’s largest network of clinical research sites.
AI & Medicine has proudly developed a unique artificial intelligence drug research and development platform to offer drug development solutions for worldwide customers from the medical institutions and pharmaceutical enterprises.
Why ÅKRN as Your Medical Device CRO? We are flexible, agile, and with solid medical device expertise. We offer optimized regulatory and clinical services tailored to our clients and MedTech partners.
Al Solutions (Al2S3) is backed by well-known industry experts. We are dedicated to making a real difference to the Life Science recruitment and staffing industry.
ALK is a global allergy solutions company, with a wide range of allergy treatments, products and services that meet the unique needs of allergy sufferers, their families and healthcare professionals.
Our team of expert consultants keep fully up to date with constantly evolving regulatory requirements, and are dedicated to ensuring that our clients are fully compliant at all stages of the medical device life-cycle.
ASLAN Pharmaceuticals is a clinical-stage oncology and immunology focused biopharmaceutical company developing novel therapeutics for global markets. We target diseases that are both highly prevalent in Asia and orphan indications in the United States and Europe.